Abstract
The current investigation aimed to determine the effects of pre-treatment of acetaminophen on seizure susceptibility and expressions of hippocampal oxidative-nitrosative stress and inflammatory markers after exposure to pentylenetetrazole administration in a mouse model. The seizure symptoms of pentylenetetrazole-treated mice were assessed using Racine classification and latency to first myoclonic jerk. Then, several parameters including TAS, TOS, NO, TNF-α, caspase-3, GABA, and glutamate levels were quantitated by commercial kits. The pre-treatment of acetaminophen significantly suppressed pentylenetetrazole-induced seizures. Also, it significantly increased the TAS and GABA values and significantly decreased the TOS, NO, TNF-α, caspase-3, and glutamate values in the hippocampus. These findings are indicative of the antiseizure potential of pre-treatment with acetaminophen in the pentylenetetrazole-induced acute seizure model of epilepsy. This effect may be due to its impact on antioxidant, anti-inflammatory, and anti-apoptotic pathways.
Similar content being viewed by others
REFERENCES
Fisher, R. S., Acevedo, C., and Arzimanoglou, A., Bogacz, A., Cross, J.H., Elger, C.E., Engel, J., Jr., Forsgren, L., French, J.A., Glynn, M., Hesdorffer, D.C., Lee, B.I., Mathern, G.W., Moshé, S.L., Perucca, E., Scheffer, I.E., Tomson, T., Watanabe, M., and Wiebe, S., Epilepsia, 2014, vol. 55, no. 4, pp. 475–478.
Chen, Z., Brodie, M. J., Liew, D., and Kwan P., JAMA Neurology, 2018, vol. 75, no. 3, pp. 279–286.
Eastman, C. L., and D’Ambrosio, R., and Ganesh, T. T, Neuropharmacology, 2019, vol. 6, pp. 107907.
Vezzani, A., French, J., Bartfai, T., and Baram, T. Z. Nature Reviews Neurology, 2011, vol. 7, no. 1, pp. 31–40.
Dhir, A. Expert Opin. Investig. Drugs, 2019, vol. 28, no. 2, pp. 191–205.
Pearson-Smith, J.N., and Patel, M. Int. J. Mol. Sci., 2017, vol. 18, pp. E2365.
Paudel, Y. N., Shaikh, M. F., Chakraborti, A., and Kumari Y., Front. Neurosci., 2018, vol. 12, no. 628, pp. 1–19.
Naziroğlu, M., Uğuz, A. C., Koçak, A., and Bal, R. J. Membr. Biol., 2009, vol. 231, pp. 57–64.
Courad, J. P., Besse, D., Delchambre, C., Hanoun N., Hamon M., Eschalier F., Caussade F., and Cloarec A., Life Sci., 2001, vol. 69, no. 12, pp. 1455–1464.
Kumpulainen, E., Kokki, H., Halonen, T., Heikkinen M., Savolainen J., and Laisalmi M., Pediatrics, 2007, vol. 119, no. 4, pp. 766–771.
Wallenstein, M.C. Arch. Int. Pharmacodyn. Ther., 1985, vol. 275, no. 1, pp. 93–104.
Deshpande, L. S. and DeLorenzo, R. J., Neuroreport, 2011, vol. 22, no. 1, pp. 15–18.
Suemaru, K., Yoshikawa, M., Tanaka, A., Araki, H., Aso, H., Watanabe, M., Epilepsy Res., 2018, vol. 140, pp. 22–28.
Maharaj, H., Maharaj, D. S., Saravanan, K. S., Mohanakumar, K. P., and Daya, S., Metab. Brain Dis., 2004, vol. 19, pp. 71–77.
Maharaj, H., Maharaj, D. S., and Daya, S., Life Sci., 2006, vol. 78, no. 21, pp. 2438–2443.
Tripathy, D. and Grammas, P., Microvasc. Res., 2009, vol. 77, no. 21, pp. 289–296.
Shin, E. J., Jeong, J. H., and Chung, Y. H. et al., Neurochem. Int., 2011, vol. 59, no. 2, pp. 122–137.
Erel, O., Clin. Biochem., 2004, vol. 37, no. 4, pp. 277–285.
Erel, O., Clin Biochem. 2005, vol. 38, no. 12, pp. 1103–1111.
Högestätt, E. D., Jönsson, B. A., and Ermund, A., Andersson, D.A., Björk, H., Alexander, J.P., Cravatt, B.F., Basbaum, A.I., Zygmunt, P.M., J. Bio. Chem., 2005, vol. 280, no. 36, pp. 31405–31412.
Solbrig, M. V., Adrian, R., Baratta, J., Piomelli, D., and Giuffrida, A. Exp. Neurol., 2005, vol. 194, no. 2, pp. 355–362.
Shubina, L., Aliev, R., and Kitchigina, V., Brain Res., 2017, vol. 1661, pp. 1–14.
Kovacs, R., Rabanus, A., Otahal, J., Patzak, A., Kardos, J., Albus, K., Heinemann, U., and Kann, O., J. Neurosci., 2009, vol. 29, no. 26, pp. 8565–8577.
Watanabe, M., Miyai, A., Danjo, S., Nakamura, Y., and Itoh, K., Exp. Neurol., 2013, vol. 247, pp. 645–652.
Björkman, R., Hallman, K. M., Hedner, J., Hedner, T., and Henning, M., Pain, 1994, vol. 57, pp. 259–264.
Glibetic, M., Parker, J., and Aranda, J., Ped. Res., 1999, vol. 45, p. 66
Galic, M. A., Riazi, K., and Pittman, Q. J., Front. Neuroendocrinol., 2012 vol. 33, no. 1, pp. 116–125.
Stellwagen, D., J. Neurosci., 2005, vol. 25, no. 12, pp. 3219–3228.
Nastevska, C., Gerber, E., Horbach, M., Röhrdanz, E., and Kahl, R., Toxicology, 1999, vol. 15, no. 133, pp. 85–92.
Young, C., Roth, K.A., Klocke, B.J., West, T., Holtzman, D.M., Labruyere, J., Qin, Y.Q., Dikranian, K., and Olney, J.W., Neurobiol. Dis., 2005, vol. 20, no. 2, pp. 608–614.
Henshall, D.C., Clark, R.S., Adelson, P.D., Chen, M., Watkins, S.C., and Simon, R.P., Neurology, 2000, vol. 55, no. 2, pp. 250–257.
Ali, A.E., Mahdy, H.M., Elsherbiny, D.M., Azab, S.S., Biochem. Pharmacol., 2018, vol. 156, pp. 431–443.
Gillardon, F., Bottiger, B., Schmitz, B., Zimmermann, M., and Hossmann, K.A., Mol. Brain Res., 1997, vol. 50, pp. 16–22.
Faherty, C.J., Xanthoudakis, S., and Smeyne, R.J., Mol. Brain Res., 1999, vol. 70, no. 1, pp. 159–163.
Tripathy, D., and Grammas, P., J. Neuroinflamm., 2009, vol. 6, pp. 1–10.
Dambach, D.M., Durham, S.K., Laskin, J.D., and Laskin, D.L., Toxicol. Appl. Pharmacol., 2006, vol. 211, no. 2, pp. 157–165.
Pires, L.F., Costa, L.M., de Almeida, A.A., Silva, O.A., Cerqueira, G.S., de Sousa, D.P., Pires, R.M.C., Satyal, P., and de Freitas, R.M., Chemico-Biol. Int., 2015, vol. 226, pp. 49–57.
ACKNOWLEDGMENTS
We would like to thank Prof. Ali Cetin, MD, Sivas Cumhuriyet University, Sivas, Turkey, for valuable comments on the manuscript.
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declared no conflict of interest.
Ethical approval. All procedures were conducted in accordance with the guidelines of the Cumhuriyet University Animal Ethics Committee for the welfare of experimental animals (Registry no. 65202830-050.04.04-385 dated 09.03.2020).
Rights and permissions
About this article
Cite this article
Karabulut, S., Taskiran, A.S. Effect of Pre-Treatment with Acetaminophen on Hippocampal Oxidative, Inflammatory, and Apoptotic Parameters in PTZ-Induced Acute Seizure Mice Model. Neurochem. J. 15, 79–85 (2021). https://doi.org/10.1134/S1819712421010050
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712421010050